Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds

Advertising today archive

2296 PWToday Stories

Abeome and CDC to Collaborate on Zika Antibody Discovery

19 Apr 17

Abeome Corporation announced today that it has signed a Research Collaboration Agreement (RCA) with Centers for Disease Control and Prevention (CDC) for the identification of novel antibodies binding to the Zika virus using Abeome's proprietary AbeoMouseTM platform.

"We are very pleased to collaborate with the CDC using our proprietary antibody discovery platform, AbeoMouseTM , for the rapid discovery of monoclonal antibodies. It is our hope that antibodies emerging from this collaboration may have significant diagnostic and therapeutic potential in the battle against Zika," stated Dr. Richard A. Shimkets, President and CEO of Abeome Corporation.

About the Collaboration: The collaborative agreement calls for the generation of novel monoclonal antibodies specifically recognizing the Zika virus, which will be validated across related viruses for diagnostic purposes, and in cell culture and animal models of Zika infection for therapeutic potential.

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.